Literature DB >> 18542822

PSA for prostate cancer detection: In serum, in urine or both?

Armen Aprikian1.   

Abstract

Entities:  

Year:  2007        PMID： 18542822      PMCID： PMC2422989          DOI： 10.5489/cuaj.449

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  2 in total

1.  Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL.

Authors:  Stéphane Bolduc; Louis Lacombe; Alain Naud; Mireille Grégoire; Yves Fradet; Roland R Tremblay
Journal:  Can Urol Assoc J       Date:  2007-11       Impact factor: 1.862

2.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245
  2 in total
  1 in total

Review 1.  The present and future of prostate cancer urine biomarkers.

Authors:  Marina Rigau; Mireia Olivan; Marta Garcia; Tamara Sequeiros; Melania Montes; Eva Colás; Marta Llauradó; Jacques Planas; Inés de Torres; Juan Morote; Colin Cooper; Jaume Reventós; Jeremy Clark; Andreas Doll
Journal:  Int J Mol Sci       Date:  2013-06-17       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.